Thrombolytic therapy in acute myocardial infarction--update 1996

Related Experiment Video

Updated: Nov 4, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

K Huber1, M S Runge, C Bode

  • 1Department of Cardiology, University of Vienna, Austria.

Annals of Hematology
|January 1, 1996
PubMed

Insights

Early and rapid thrombolytic treatment for acute myocardial infarction (MI) improves patient outcomes. Achieving rapid reperfusion and sustained artery flow is key to reducing mortality and preserving heart function.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute myocardial infarction (MI) remains a leading cause of mortality despite recent therapeutic advancements.
  • Current "front-loaded" recombinant tissue plasminogen activator (rt-PA) regimens show limitations, with 30-day mortality at 6.3% and fatal cerebral hemorrhage in 1.5% of cases.

Purpose of the Study:

  • To identify strategies for improving short- and long-term prognoses in acute MI patients treated with thrombolytics.
  • To determine the impact of early intervention and reperfusion success on patient outcomes.

Main Methods:

  • Analysis of treatment regimens for acute myocardial infarction.
  • Evaluation of the relationship between thrombolytic infusion timing, reperfusion speed, and artery flow.
  • Assessment of ventricular function preservation and outcome prediction.

Main Results:

  • Early initiation of thrombolytic agent infusion is crucial for improved patient prognosis.
  • Rapid reperfusion and achieving persistent TIMI grade 3 flow in the infarct-related artery are critical.
  • These factors are directly linked to optimal preservation of ventricular function.

Conclusions:

  • Optimizing thrombolytic therapy requires early administration and rapid achievement of sustained artery patency.
  • Successful reperfusion and preserved ventricular function are key predictors of favorable outcomes in acute MI patients.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...